20/20 GeneSystems News Archives

 Return to 'News' page

 

Nov 29, 2004 20/20 and Novartis Begin Project

nov 11, 2004 20/20 and Celgene Enter 2nd Phase of Project

Sep 8 , 2004 20/20 Receives a $96,489 Phase I SBIR Award to Develop a Clinical Diagnostic Tool for Monitoring Patients treated with receptor Tyrosine Kinase Inhibitors

july 8 , 2004 20/20 and Celgene Developing a Monitoring Tool

June 2, 2004 20/20 Successfully Completes Phase I NCI SBIR Contract


April 26, 2004  20/20 Receives SBIR Award to Develop Tool to Profile Patients with Breast  Cancer

 

April 8, 2004 20/20 Awarded SBIR Grant to Develop a Clinical Diagnostic Tool

April 6, 2004 20/20 Receives SBIR Grant  to Develop a Method of Profiling Patients with Kidney Cancer

 

Feb. 10, 2003   20/20 Launches Innovative Bio-Terrorism Field Test for 1st Responders

Oct 8, 2002 20/20 Enters Technology Access Agreement with Novartis Pharmaceuticals


Sept. 9, 2002  20/20 Receives $50,000 Award from TEDCO

July 29, 2002 20/20 GeneSystems Receives a Quarter of a Million Dollars in Funding from Agencies Promoting Maryland Biotech

Feb. 4, 2002 20/20 GeneSystems Enters Far East Distribution Agreement  with Wako Pure Chemical Industries for Proteomics Product

 

October 17, 2001 Application of Layered Proteomics Technology to Analysis of Plastic Embedded Tissue Sections 

Oct. 2, 2001 20/20 GeneSystems Launches New Proteomics Product

Aug. 20,2001 David Sidransky To Chair Scientific Board Of 20/20 GeneSystems  Johns Hopkins Researcher Named “America’s Best Oncologist” by TIME Magazine